HOME › DRUGS › ALIROCUMAB
ACTIVE SUBSTANCE / INN

ALIROCUMAB

Brand name(s): Praluent, PRALUENT
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
BLA125559
Dyslipidemias
ACTIVE SUBSTANCE
Alirocumab
REGULATORS
FDA · EMA
SPONSORS / MAH
Sanofi Winthrop Industrie, REGENERON PHARMACEUTICALS
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
PRALUENTBLA125559REGENERON PHARMACEUTICALSPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
PraluentSanofi Winthrop IndustrieAuthorised23/09/2015Dyslipidemias

FULL INTELLIGENCE ON ALIROCUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →